Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...

The S&P 500 turned higher on Tuesday afternoon after a weak start, as the Senate's passage of U.S. President Donald Trump's ...

Amgen and Zai Lab have reported that the Phase III FORTITUDE-101 trial, assessing bemarituzumab in combination with ...

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the following day. Its shares closed the trading session more than 4% ...

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Amgen acquired Five Prime in 2021 on the back of the phase 2 FIGHT trial of bemarituzumab, which achieved significant ...

The Dow Jones Industrial Average is rallying Tuesday afternoon with shares of Amgen and Merck delivering the strongest returns for the blue-chip average.

Buoyed by positive gains for shares of Amgen and Merck, the Dow Jones Industrial Average is climbing Tuesday morning. Supported by world-class markets data from Dow Jones and FactSet, and partnering ...

The S&P 500 and Nasdaq retreated from record highs as Tesla's stock dipped following renewed tensions between Elon Musk and ...

NEW YORK: The S&P 500 and the Nasdaq dropped from record highs on Tuesday, as Tesla shares were hit by a renewed spat between ...

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the ...

(Reuters) -The S&P 500 and the Nasdaq dropped from record highs on Tuesday, as Tesla shares were hit by a renewed spat ...